» Articles » PMID: 32503088

A Systematic Review of Neurological Manifestations of SARS-CoV-2 Infection: the Devil is Hidden in the Details

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2020 Jun 6
PMID 32503088
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: We systematically reviewed available evidence for reports of neurological signs and symptoms in patients with COVID-19 to identify cases with severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection or immune-mediated reaction in the nervous system.

Methods: We followed PRISMA guidelines and used the MEDLINE, EMBASE, Google Scholar, MedRxiv and ChinaXiv databases to search for articles on COVID-19 and nervous system involvement that were published from 1 January to 24 April 2020. Data on design, sample size, neurological assessment and related work-up were extracted. Biases were assessed with the Newcastle-Ottawa scale.

Results: We analysed 27 publications on potential neuroinvasive or parainfectious neurological complications of COVID-19. The reports focused on smell and taste (n = 5) and evaluation of neurological symptoms and signs in cohorts (n = 5). There were cases of Guillain-Barré syndrome/Miller-Fisher syndrome/cranial neuropathy (seven cases), meningitis/encephalitis (nine cases) and various other conditions (five cases). The number of patients with examination of cerebrospinal fluid and, in particular, SARS-CoV-2 polymerase chain reaction was negligible. Two had a positive SARS-CoV-2 polymerase chain reaction examination of cerebrospinal fluid specimen. Study of potential parenchymal involvement with magnetic resonance imaging was rare. Only four reports received a rating of the highest quality standards.

Conclusions: This systematic review failed to establish comprehensive insights into nervous system manifestations of COVID-19 beyond immune-mediated complications in the aftermath of respiratory symptoms. The authors therefore provide guidance for more careful clinical, diagnostic and epidemiological studies to characterize the manifestations and burden of neurological disease caused by SARS-CoV-2 on behalf of the Infectious Disease Panel of the European Academy of Neurology.

Citing Articles

Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX).

Pupillo E, Bianchi E, Beghi E, Pedrazzini F, Giglio A, Schilke E Sci Rep. 2025; 15(1):4179.

PMID: 39905221 PMC: 11794632. DOI: 10.1038/s41598-025-88837-0.


The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future.

Cavallieri F, Sellner J, Akhvlediani T, Bassetti C, Bereczki D, Fanciulli A Eur J Neurol. 2024; 32(1):e16321.

PMID: 38676302 PMC: 11618110. DOI: 10.1111/ene.16321.


Temporal trends of ambulance time intervals for suspected stroke/transient ischaemic attack (TIA) before and during the COVID-19 pandemic in Ireland: a quasi-experimental study.

Burton E, Quinn R, Crosbie-Staunton K, Deasy C, Masterson S, ODonnell C BMJ Open. 2024; 14(3):e078168.

PMID: 38508613 PMC: 10961584. DOI: 10.1136/bmjopen-2023-078168.


The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics.

Rakusa M, Moro E, Akhvlediani T, Bereczki D, Bodini B, Cavallieri F Eur J Neurol. 2023; 31(3):e16168.

PMID: 38038262 PMC: 11235678. DOI: 10.1111/ene.16168.


The association between epilepsy and COVID-19: analysis based on Mendelian randomization and FUMA.

You M, Yuan P, Li L, Li B, Peng Z, Xu H Front Neurosci. 2023; 17:1235822.

PMID: 37781245 PMC: 10540302. DOI: 10.3389/fnins.2023.1235822.


References
1.
Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M . Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol. 2020; 27(9):e43-e44. PMC: 7267660. DOI: 10.1111/ene.14298. View

2.
Venkatesan A, Jagdish B . Imaging in Encephalitis. Semin Neurol. 2019; 39(3):312-321. DOI: 10.1055/s-0039-1687838. View

3.
Lu L, Xiong W, Liu D, Liu J, Yang D, Li N . New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia. 2020; 61(6):e49-e53. PMC: 7264627. DOI: 10.1111/epi.16524. View

4.
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View

5.
Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View